Progress Updates
January 6, 2022
Big data helps in understanding asthma biologic use, outcomes
According to the Centers for Disease Control and Prevention, about 25 million Americans have asthma, and that number is increasing every year. In the last 10 years, a number of new medications have become available. Collectively referred to as ‘biologics,’ these therapies are made to target very specific parts of the body and its immune […]
Tags: asthma, big data, Che Ngufor, inflammation, Jacob Maddux, Matthew Rank, Molly Jeffery, Nilay Shah, OptumLabs
November 22, 2021
Advancements in opioids research, beyond surgical prescribing practices
In “An Institutional Approach to Managing the Opioid Crisis,” the authors describe the elements of Mayo Clinic’s Opioid Stewardship Program. The study’s first author, Halena Gazelka, M.D., an anesthesiologist, is chair of the program. She works together with the study’s senior author, Elizabeth Habermann, Ph.D., deputy director of research in the Mayo Clinic Robert D. […]
Tags: Andy Abril, Barbara Bruce, Caitlin Brown, Cassandra Ramel, Center for the Science of Health Care Delivery, Cornelius Thiels, COVID-19, depression, Elizabeth Habermann, emergency department, Evidence-based Practice Center, Fernando Rivera
November 16, 2021
Patient-focused research to transform experience for manual wheel chair users
A multidisciplinary team of Mayo Clinic researchers and others is looking at the ergonomics of people who use manual wheelchairs. They seek to identify metrics to quantify arm use associated with rotator cuff pathology and progressive degeneration, which will inform development of personalized interventions. In general, people lose functionality in their rotator cuffs — the […]
Tags: biomedical research, Center for the Science of Health Care Delivery, collaboration, disability-related research, ergonomics, health care systems engineering, Melissa Morrow, National Institutes of Health
November 8, 2021
Advancements in opioids research, transformations in postsurgical prescribing
In an effort to address the prescription opioid epidemic by reducing unnecessary or excess opioid prescriptions, the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery has been leading Mayo’s research on prescribing practices. Much of this work has been directed by Elizabeth B. Habermann, Ph.D., Deputy Director […]
Tags: Aakriti Carrubba, Adyr Moss, Amanda Stanton, Amit Mathur, Ansh Goyal, C. Burcin Taner, carpal tunnel syndrome, Center for the Science of Health Care Delivery, Cody Wyles, Cornelius Thiels, Cristopher Destephano, David Warner
October 12, 2021
What’s the best treatment for this condition? The Knowledge Synthesis team can help.
Knowledge synthesis is a key component of health care delivery research in which all available evidence on a particular topic is summarized through comprehensive literature searches and analyzed using advanced qualitative and quantitative synthesis methods. The Knowledge Synthesis Program in the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health […]
Tags: artificial intelligence, big data, Center for the Science of Health Care Delivery, clinical trials, Evidence-based Practice Center, health technology, Irbaz Riaz, kidney cancer, knowledge synthesis, liver disease, M. Hassan Murad, medical innovation
August 10, 2021
Mayo Clinic Research in the news — 8/9/2021
By Advancing the Science contributor 
COVID-19 has once again taken almost all the headlines. However, research and expertise across the vastness of medicine still continues. Those stories are at the top — dancing after menopause, hemp seeds for inflammation, ‘brain orgasms’, and more. Then read on for the latest understanding in why the delta variant spreads even among vaccinated people, […]
Tags: Abinash Virk, Ala Dababneh, Angela Dispenzieri, antibodies, arthritis, Arya Mohabbat, cancer, cardiology, chemotherapy, COVID-19, dementia, Devang Sanghavi
July 19, 2021
Mayo Clinic Research in the news — 7/19/2021
By Advancing the Science contributor
Mayo research and faculty expertise were cited on topics such as the health benefits of a pet, narcolepsy, the benefits of second opinions for patient outcomes, hiccups, COVID-19 modeling and a variety of other healthcare concerns. Star Tribune, Competing models at start of pandemic hurt public’s trust … Mayo leaders in spring 2020 reached out […]
Tags: Abinash Virk, aging, Alzheimer's disease, Andrew Badley, Andrew Jagim, anemia, animal model, antiplatelet, anxiety, artificial intelligence, bioethics, biomedical ethics
June 28, 2021
Mayo Clinic Research in the news — 6/28/2021
By Advancing the Science contributor
Vaping, medical AI, the challenges of serving patients with cancer and diabetes, current COVID-19 vaccine and long haul information, and a wide selection of other topics are covered in this week’s news. The Vaping Study You Haven’t Heard Of Slate, 6/25/2021 A report from the Mayo Clinic looked at 70,000 patients and found no link […]
Tags: Alzheimer's disease, antibodies, artificial intelligence, Ashley Wentworth, autoimmune disorder, Barbara Barry, bioethics, biomedical ethics, cancer, cardiovascular disease, Center for Regenerative Medicine, COVID-19
June 15, 2021
Transforming medicine for patients with respiratory diseases
The Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery provides a unique service for Mayo Clinic. Embedded in the medical practice, its objective is to transform the practice of medicine – from the inside out. Center researchers work within multidisciplinary teams to identify areas for improvement within […]
Tags: Aahd Kubbara, acute respiratory illness, Alanna Chamberlain, Andrew Limper, Ann Vu, antifungal, biomedical research, Cassie Kennedy, Center for the Science of Health Care Delivery, chronic obstructive pulmonary disease, COPD, COVID-19
June 14, 2021
Mayo Clinic Research in the news — 6/14/2021
By Advancing the Science contributor
Read on for news of the week that includes Mayo Clinic Research and research experts. Topics include a new Alzheimer’s medication, COVID-19, and various regenerative medicine innovations. US approves first new Alzheimer’s drug in 20 years BBC, 6/8/2021 A controversial drug to treat Alzheimer’s disease has been approved by the Food and Drug Administration in […]
Tags: aging, Alzheimer's disease, Andre Terzic, animal model, biomedical ethics, brain, BRCA1, breast cancer, cancer, Center for Regenerative Medicine, Cheryl Willman, concussion